Premature Infant Exposure to Noise Generated by Respiratory Support

University of Virginia

Status: Completed

Conditions: Premature Birth of Newborn

Study type: Observational

Funder types: Other

Identifiers

NCT01748214

13164

Details and patient eligibility

About

Infants in neonatal intensive care units are increasing exposed to non-invasive ventilatory support modes (nasal continuous positive airway pressure - NCPAP and high flow nasal cannula: >1 L/min flow - HFNC). While there have been small descriptive studies of noise exposure in infants on NCPAP, there have been no comparative trials done comparing noise exposure in infants undergoing both NCPAP and HFNC.

Objective: Using a cross-over model determine noise exposure levels in infants exposed to similar levels of respiratory support provided by NCPAP and HFNC.

Full description

Infants born < 32 weeks, in an incubator, and > 7 days postnatal that were maintained on either on NCPAP or HFNC to maintain SaO2 in a range of 88 - 92 %. Study infants had decibel measurements obtained every 15 seconds for 30 minutes using a noise dosimeter (NoisePro DLX-1). The microphone for the dosimeter was suspended from the inside of the incubator such that it hung 1 foot above the infants nose and mouth. The exhalation port for NCPAP was placed outside of the incubator. Repeated measurement periods on the same mode of support were made within a 72 hour period. Each infant the acted as their own control and was switched within 7 days to the alternative respiratory support method that maintained similar SaO2 goals and repeat measurements were obtained. Comparisons of mean decibel levels during recording were compared using paired t-tests.

Enrollment: 28 patients

Sex: All

Ages: 7+ days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Premature infant born < 32 weeks and 0 days post-conceptional age;
• Seven or more days of age and not in acute respiratory distress;
• Need for nasal continuous positive airway pressure or high-flow nasal cannula for ventilation or supplemental oxygen delivery;
• In a neutral-thermal environment (i.e. isolette)

Exclusion criteria

• Oro-facial congenital anomalies;
• Congenital heart disease (except for patent ductus arteriosus and/or patent foramen ovale);
• Unstable respiratory status as deemed by the attending physician
• Patients under isolation for infectious disease

Trial design

28 participants in 2 patient groups

Nasal CPAP

Description:

Infants received nasal CPAP as standard of care.

High Flow Nasal Cannual

Description:

Infants received high flow nasal cannula as standard of care.